BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

8605 related articles for article (PubMed ID: 12850810)

  • 1. Endogenous accumulation of IFN-gamma in IFN-gamma-R(-/-) mice increases resistance to B16F10-Nex2 murine melanoma: a model for direct IFN-gamma anti-tumor cytotoxicity in vitro and in vivo.
    Rodrigues EG; Garofalo AS; Travassos LR
    Cytokines Cell Mol Ther; 2002; 7(3):107-16. PubMed ID: 12850810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy with interleukin-10 receptor and interleukin-12 induces a protective interferon-γ-dependent response against B16F10-Nex2 melanoma.
    Marchi LH; Paschoalin T; Travassos LR; Rodrigues EG
    Cancer Gene Ther; 2011 Feb; 18(2):110-22. PubMed ID: 20885448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-12 is dysregulated in macrophages from IRF-1 and IRF-2 knockout mice.
    Salkowski CA; Kopydlowski K; Blanco J; Cody MJ; McNally R; Vogel SN
    J Immunol; 1999 Aug; 163(3):1529-36. PubMed ID: 10415056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-11-induced reduction of C/EBP transcription factor binding may contribute to the IL-12 downregulation in tumor-bearing mice.
    Torroella-Kouri M; Keith JC; Ivanova M; Lopez DM
    Int J Oncol; 2003 Feb; 22(2):439-48. PubMed ID: 12527946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of inducible nitric oxide synthase and IL-12 between peritoneal and splenic macrophages stimulated with LPS plus IFN-gamma is associated with the activation of extracellular signal-related kinase.
    Zhu YN; Yang YF; Ono S; Zhong XG; Feng YH; Ren YX; Ni J; Fu YF; Tang W; Zuo JP
    Int Immunol; 2006 Jun; 18(6):981-90. PubMed ID: 16636012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subtherapeutic doses of interleukin-15 augment the antitumor effect of interleukin-12 in a B16F10 melanoma model in mice.
    Lasek W; Golab J; Maśliński W; Switaj T; Bałkowiec EZ; Stokłosa T; Giermasz A; Malejczyk M; Jakóbisiak M
    Eur Cytokine Netw; 1999 Sep; 10(3):345-56. PubMed ID: 10477391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of IFN-gamma production by TNF-alpha in macrophages from the tumor environment: significance as an angiogenic switch.
    Lee H; Baek S; Joe SJ; Pyo SN
    Int Immunopharmacol; 2006 Jan; 6(1):71-8. PubMed ID: 16332515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of interferon-gamma in interleukin 12-induced pathology in mice.
    Car BD; Eng VM; Schnyder B; LeHir M; Shakhov AN; Woerly G; Huang S; Aguet M; Anderson TD; Ryffel B
    Am J Pathol; 1995 Dec; 147(6):1693-707. PubMed ID: 7495294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipopolysaccharide and ceramide use divergent signaling pathways to induce cell death in murine macrophages.
    Lakics V; Vogel SN
    J Immunol; 1998 Sep; 161(5):2490-500. PubMed ID: 9725248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological functions of IFN-gamma and IFN-alpha/beta: lessons from studies in gene knockout mice.
    Kamijo R; Shapiro D; Gerecitano J; Le J; Bosland M; Vilcek J
    Hokkaido Igaku Zasshi; 1994 Nov; 69(6):1332-8. PubMed ID: 7705746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor is required for the priming of peritoneal macrophages by trehalose dimycolate.
    Oswald IP; Dozois CM; Fournout S; Petit JF; Lemaire G
    Eur Cytokine Netw; 1999 Dec; 10(4):533-40. PubMed ID: 10586120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulatory effect of killed Propionibacterium acnes and its purified soluble polysaccharide on peritoneal exudate cells from C57Bl/6 mice: major NKT cell recruitment and increased cytotoxicity.
    Ananias RZ; Rodrigues EG; Braga EG; Squaiella CC; Mussalem JS; Longhini AL; Travassos LR; Longo-Maugéri IM
    Scand J Immunol; 2007 Jun; 65(6):538-48. PubMed ID: 17523946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-induced suppression of interferon-gamma production and enhancement of interleukin-10 production by natural killer (NK) cells: paralleled to CD4+ T cells.
    Wei H; Zheng X; Lou D; Zhang L; Zhang R; Sun R; Tian Z
    Mol Immunol; 2005 May; 42(9):1023-31. PubMed ID: 15829292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IFN regulatory factor-1 gene transfer into an aggressive, nonimmunogenic sarcoma suppresses the malignant phenotype and enhances immunogenicity in syngeneic mice.
    Yim JH; Wu SJ; Casey MJ; Norton JA; Doherty GM
    J Immunol; 1997 Feb; 158(3):1284-92. PubMed ID: 9013971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of effects of CH50 on macrophage activation and its anti-tumor activity with those of lipopolysaccharides.
    Zhang GM; Feng ZH; Li D; Zhang H
    Acta Pharmacol Sin; 2000 Jun; 21(6):567-70. PubMed ID: 11360693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IFN-gamma-independent synergistic effects of IL-12 and IL-15 induce anti-tumor immune responses in syngeneic mice.
    Comes A; Di Carlo E; Musiani P; Rosso O; Meazza R; Chiodoni C; Colombo MP; Ferrini S
    Eur J Immunol; 2002 Jul; 32(7):1914-23. PubMed ID: 12115611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antitumor effect of M-CSF and/or IFN-gamma gene cotransfected-macrophages by intratumoral injection].
    Lei H; Cao X; Yu Y
    Zhonghua Zhong Liu Za Zhi; 1998 May; 20(3):174-7. PubMed ID: 10920999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous IL-1 is required for neutrophil recruitment and macrophage activation during murine listeriosis.
    Rogers HW; Tripp CS; Schreiber RD; Unanue ER
    J Immunol; 1994 Sep; 153(5):2093-101. PubMed ID: 8051414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effects of cyclooxygenase-2 inhibitor celecoxib against toxicity of LPS-stimulated macrophages toward motor neurons.
    Huang Y; Liu J; Wang LZ; Zhang WY; Zhu XZ
    Acta Pharmacol Sin; 2005 Aug; 26(8):952-8. PubMed ID: 16038627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of protein kinase C and not of NF kappa B in the modulation of macrophage nitric oxide synthase by tumor-derived phosphatidyl serine.
    Calderon CL; Torroella-Kouri M; Dinapoli MR; Lopez DM
    Int J Oncol; 2008 Mar; 32(3):713-21. PubMed ID: 18292949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 431.